Regression of feline immunodeficiency virus infection

AIDS Research and Human Retroviruses

Volumn 13, Issue 8, 1997, Pages 713-718

  O'Neil, Lynne L ^a   Burkhard, Mary Jo ^a   Obert, Leslie A ^a   Hoover, Edward A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CAT; DISEASE COURSE; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS DETECTION; VIRUS INFECTION;

EID: 0030952728     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.713     Document Type: Article

References (21)

1. Cao Y, Qin L, Zhang L, Safrit J, and Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-208.
2. Rinaldo C, Huang XL, Fan Z, Ding M, Beltz L, Logar A, Panicali D, Mazzara G, Liebmann J, Cottrill M, and Gupta P: High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 1995;69:5838-5842.
3. Klein MR, van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, Keet IPM, Eeftinck-Schattenkerk JKM, Osterhaus ADME, Schuitemaker H, and Miedema F: Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-1372.
4. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schrager LK, Margolick JB, Buchbinder S, Giorgi JV, and Fauci AS: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-216.
5. Bryson YJ, Pang S, Wei LS, Dickover R, Diane A, and Chen ISY: Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995;332:833-838.
6. Newell ML, Dunn D, DeMaria A, Ferrazin A, De Rossi A, Giazuinto C, Levy J, Alimenti A, Ehrnst A, Bohlin AB, Ljung R, and Peckham C: Detection of virus in vertically exposed HIV-antibody-negative children. Lancet 1996;347:213-215.
7. Roques PA, Gras G, Parnet-Mathieu F, Mabondzo AM, Dollfus C, Narwa R, Marcé D, Tranchot-Diallo J, Hervé F, Lasfargues L, Courpotin C, and Dormont D: Clearance of HIV infection in 12 perinatally infected children: Clinical, virological and immunological data. AIDS 1995;9:F19-F26.
8. Israel ZR, Edmonson PF, Maul DH, O'Neil SP, Mossman SP, Thiriart C, Fabry L, Van Opstal O, Bruck C, Bex F, Burny A, Fultz PN, Mullins JI, and Hoover EA: Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. J Virol 1994;68:1843-1853.
9. Hu S-L, Abrams K, Barber GN, Moran P, Zarling JM, Langlois AJ, Kuller L, Morton WR, and Benveniste RE: Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 1992;255:456-459.
10. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, and Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-1941.
11. Clements JE, Montelaro RC, Zink MC, Amedee AM, Miller S, Trichel AM, Jagerski B, Hauer D, Martin LN, Bohm RP, and Murphey-Corb M: Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol 1995;69:2737-2744.
12. Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, and Desrosiers RC: Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 1996;70:3724-3733.
13. Sodora DL, Shpaer EG, Kitchell BE, Dow SW, Hoover EA, and Mullins JI: Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol 1994;68:2230-2238.
14. Dreitz MJ, Dow SW, Fiscus SA, and Hoover EA: Developmental of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus. Am J Vet Res 1995;56:764-768.
15. O'Reilly KL and Hoover EA. Characterization of a panel of monoclonal antibodies specific for subsets of feline leukocytes. In: The Second International Feline Retrovirus Symposium (Tompkins WA, ed.). North Carolina State University, Raleigh, North Carolina, 1993, p. 38.
16. Dean GA, Quackenbush SL, Ackley CD, Cooper MD, and Hoover EA: Flow cytometric analysis of T-lymphocyte subsets in cats. Vet Immunol Immunopathol 1991;28:327-335.
17. O'Neil LL, Burkhard MJ, Diehl LJ, and Hoover EA: Vertical transmission of feline immunodeficiency virus. AIDS Res Hum Retroviruses 1995;11:171-182.
18. O'Neil LL, Burkhard MJ, and Hoover EA: Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J Virol 1996;70:2894-2901.
19. Diehl LJ, Mathiason-DuBard CK, O'Neil LL, and Hoover EA: Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR. J Virol 1995;69:2328-2332.
20. Diehl LJ, Mathiason-DuBard CK, O'Neil LL, Obert LA, and Hoover EA: Induction of accelerated feline immunodeficiency virus disease by acute phase virus passage. J Virol 1995;69:6149-6157.
21. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, and Ho DD: Temporal associations of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68: 4650-4655.